| Literature DB >> 30064381 |
Liyuan Wu1, Jiahua Yu1, Qiufang Shen1, Lu Huang1, Dezhi Wu2, Guoping Zhang1.
Abstract
BACKGROUND: Barley is relatively sensitive to Aluminum (Al) toxicity among cereal crops, but shows a wide genotypic difference in Al tolerance. The well-known Al-tolerant mechanism in barley is related to Al exclusion mediated by a citrate transporter HvAACT1 (Al-activated citrate transporter 1). A 1-kb insertion in the promoter region of HvAACT1 gene results in a dramatic increase of its expression level, which only occurs in some Al-tolerant cultivars. However, Al-tolerant Tibetan wild barley accession XZ29 did not have the 1-kb insertion.Entities:
Keywords: Aluminum resistance; Root growth; Small RNA sequencing; Target genes; Tibetan wild barley; miRNA
Mesh:
Substances:
Year: 2018 PMID: 30064381 PMCID: PMC6069884 DOI: 10.1186/s12864-018-4953-x
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1The difference in Al tolerance among three barley genotypes. a-c, Growth of Golden Promise (GP) (a),XZ29 (b) and Dayton (c) at different Al concentration. Three-day–old seedlings were exposed to Al for 9 days. Relative root elongation (d) and the whole root Al concentration (e) in three genotypes. Data are means ±SD of six and three biological replicates for d and e respectively, and means labeled with different letters are significantly different at p < 0.05 by Tukey’ test
Fig. 2The difference in 1-kb insertion, HvAACT1 expression and organic acids secretion among three barley genotypes. a Detection of 1-kb insertion in the upstream of HvAACT1 coding region. b Expression level of HvAACT1. Two root segments (0-1 cm and 1-2 cm from tips) from four-day-old seedlings were sampled after exposure to 10 μM Al for 6 h. Actin was used as an internal control and expression relative to 1-2 cm root segments of Golden Promise (GP) is shown. Al-induced citrate (c), malate and oxalate (d) secretion. Root exudates were collected after four-day-old seedlings were exposed to 10 μM Al for 6 h. Data in b, c and d are means ± SD of three biological replicates and means labeled with different letters are significantly different at p < 0.05 by Tukey’ test
The profiles of small RNA deep sequencing for the two barley genotypes under different Al treatments
| Library type | Golden Promise-Control | Golden Promise-Al | XZ29-control | XZ29-Al | ||||
|---|---|---|---|---|---|---|---|---|
| Total reads | Unique reads | Total reads | Unique reads | Total reads | Unique reads | Total reads | Unique reads | |
| Raw reads | 11,574,070 | 2,543,454 | 11,798,931 | 3,336,429 | 11,004,065 | 2,783,930 | 12,720,633 | 2,389,395 |
| Cut adapter and length filter | 3,207,755 | 967,414 | 2,299,195 | 1,121,113 | 2,424,530 | 830,285 | 2,849,733 | 908,411 |
| Junk reads | 120,196 | 23,277 | 113,489 | 34,527 | 96,376 | 25,693 | 132,744 | 20,175 |
| Rfam | 1,164,361 | 37,372 | 1,586,198 | 41,593 | 1,177,236 | 34,644 | 2,698,268 | 38,246 |
| mRNA | 2,052,214 | 61,746 | 3,482,187 | 65,806 | 2,162,010 | 53,694 | 3,360,733 | 90,151 |
| Repeats | 18,200 | 713 | 11,739 | 342 | 15,180 | 543 | 49,047 | 848 |
| valid reads | 5,487,588 | 1,464,860 | 5,379,474 | 2,086,577 | 5,608,740 | 1,850,953 | 4,495,143 | 1,346,101 |
Fig. 3The identified miRNAs from roots of Golden Promise (GP) and XZ29. a Number of miRNAs in control and Al-treated roots of two genotypes. b Length distribution of total identified miRNAs. A total of 342 miRNAs were found. They were divided into three classes: known miRNAs, new members of known miRNAs and potentially candidate miRNAs
miRNAs in response to Al stress
| miRNA name | GPa | XZ29b | Transcript | Annotation | Degradome detectionc |
|---|---|---|---|---|---|
| ata-miR156a-3p | 0.20 | 0.89 | HORVU3Hr1G072810.1 | Gibberellin 2-oxidase | Y |
| ata-miR156a-5p | −0.49 | 0.91 | HORVU3Hr1G094730.2 | Squamosa promoter-binding-like protein 2 | Y |
| HORVU6Hr1G019700.2 | Squamosa promoter-binding-like protein 3 | Y | |||
| bdi-miR156h-3p | 0.33 | −1.15 | HORVU4Hr1G025850.7 | Structure-specific endonuclease subunit slx1 | N |
| HORVU4Hr1G012480.3 | Leucine-rich receptor-like protein kinase family protein | N | |||
| hvu-miR159a | −0.21 | −0.67 | HORVU3Hr1G079490.4 | MYB domain protein 33 | Y |
| hvu-MIR159a-5p | −0.44 | −1.36 | HORVU1Hr1G088510.1 | Mitogen-activated protein kinase 16 | N |
| osa-miR319a-3p.2-3p | −0.35 | 0.76 | HORVU5Hr1G103400.1 | TCP family transcription factor 4 | Y |
| HORVU2Hr1G060120.1 | TCP family transcription factor 4 | Y | |||
| ata-miR160a-5p | −0.44 | −0.77 | HORVU2Hr1G089670.2 | Auxin response factor 10 | Y |
| HORVU7Hr1G101270.6 | Auxin response factor 16 | Y | |||
| HORVU6Hr1G026750.1 | Auxin response factor 18 | Y | |||
| HORVU1Hr1G041770.6 | Auxin response factor 22 | Y | |||
| ata-miR164c-3p | 0.37 | 0.63 | HORVU6Hr1G088160.5 | Quinone oxidoreductase | Y |
| hvu-miR166a | −0.82 | −1.61 | HORVU5Hr1G010650.1 | Homeobox-leucine zipper protein family | Y |
| HORVU5Hr1G061410.29 | Homeobox-leucine zipper protein HOX10 | Y | |||
| HORVU0Hr1G010250.3 | Homeobox-leucine zipper protein HOX32 | Y | |||
| HORVU1Hr1G041790.2 | Homeobox-leucine zipper protein family | Y | |||
| ata-miR166a-3p | −0.54 | −1.84 | HORVU0Hr1G010250.3 | Homeobox-leucine zipper protein HOX32 | N |
| ata-miR166a-5p | −0.71 | −0.03 | HORVU5Hr1G056820.4 | Histidine protein methyltransferase 1 homolog | N |
| ata-miR166d-5p | −0.53 | −0.29 | HORVU4Hr1G018020.2 | F-box/WD-40 repeat-containing protein | N |
| ata-miR167a-5p | −0.63 | −0.17 | HORVU2Hr1G121110.32 | Auxin response factor 6 | Y |
| ata-miR167b-3p | −0.92 | −0.71 | HORVU1Hr1G075520.2 | Jacalin-related lectin 3 | N |
| ata-miR167b-5p | 0.58 | −0.23 | HORVU2Hr1G059280.1 | SWI/SNF complex subunit SWI3C | N |
| tae-miR167c-5p | 0.64 | −2.00 | HORVU1Hr1G077630.2 | Ubiquitin carboxyl-terminal hydrolase 25 | N |
| HORVU2Hr1G059280.1 | SWI/SNF complex subunit SWI3C | N | |||
| ata-miR167f-3p | 0.29 | 0.84 | HORVU4Hr1G016990.3 | Cysteine desulfurase | N |
| hvu-miR168-3p | −0.71 | 1.04 | HORVU5Hr1G037570.4 | Receptor-like protein kinase | N |
| hvu-miR168-5p | −0.55 | −0.83 | HORVU1Hr1G055570.4 | WD repeat-containing protein WRAP73 | Y |
| ata-miR169i-5p | 0.42 | −1.58 | HORVU5Hr1G092700.17 | Nuclear transcription factor Y subunit A-10 | Y |
| HORVU4Hr1G075830.4 | Nuclear transcription factor Y subunit A-3 | Y | |||
| HORVU6Hr1G081080.12 | Nuclear transcription factor Y subunit A-5 | Y | |||
| ata-miR169d-5p | −0.46 | −0.86 | HORVU5Hr1G092700.17 | Nuclear transcription factor Y subunit A-10 | Y |
| HORVU4Hr1G075830.4 | Nuclear transcription factor Y subunit A-3 | Y | |||
| HORVU6Hr1G081080.12 | Nuclear transcription factor Y subunit A-5 | Y | |||
| ata-MIR169d-3p | −0.91 | −1.82 | HORVU5Hr1G089950.4 | Chromodomain-helicase-DNA-binding protein Mi-2 homolog | N |
| ata-miR169h-3p | −0.81 | 0.18 | HORVU1Hr1G075540.3 | Mitochondrial processing peptidase alpha subunit | Y |
| ata-miR171b-5p | −0.70 | 0.14 | HORVU5Hr1G081160.4 | U-box domain-containing protein 73 | N |
| ata-miR171a-5p | −1.42 | −1.15 | HORVU2Hr1G076620.7 | T-complex protein 11 | Y |
| ata-miR172b-3p | −0.63 | −0.55 | HORVU5Hr1G112440.1 | Ethylene-responsive transcription factor 10 | Y |
| HORVU1Hr1G011800.24 | AP2-like ethylene-responsive transcription factor | Y | |||
| ata-miR390-5p | −1.86 | −0.56 | HORVU7Hr1G007520.1 | Leucine-rich repeat receptor-like protein kinase family protein | N |
| ata-miR393-5p | −0.16 | −1.57 | HORVU2Hr1G070800.3 | HvAFB | Y |
| HORVU1Hr1G021550.4 | HvTIR1 | Y | |||
| ata-miR394-5p | −1.18 | −0.30 | HORVU1Hr1G043940.3 | Protein TIC110, chloroplastic | N |
| HORVU6Hr1G018370.1 | Calnexin 1 | N | |||
| ata-miR396a-5p | 0.16 | −1.20 | HORVU7Hr1G008680.14 | Growth-regulating factor 5 | Y |
| HORVU4Hr1G010080.6 | Growth-regulating factor 6 | Y | |||
| HORVU4Hr1G003440.12 | Growth-regulating factor 9 | Y | |||
| ata-miR396e-5p | 0.51 | −1.46 | HORVU7Hr1G008680.14 | Growth-regulating factor 5 | Y |
| HORVU4Hr1G010080.6 | Growth-regulating factor 6 | Y | |||
| HORVU4Hr1G003440.12 | Growth-regulating factor 9 | Y | |||
| osa-miR444a-3p.2 | −0.14 | −0.82 | HORVU2Hr1G080490.1 | MADS-box transcription factor 27 | Y |
| ppt-miR477h | 1.34 | 2.83 | HORVU1Hr1G050450.2 | Replication factor C subunit 5 | N |
| osa-miR827 | −0.46 | −1.26 | HORVU6Hr1G065710.13 | SPX domain-containing membrane protein | N |
| ata-miR1432-5p | −1.56 | 0.21 | HORVU1Hr1G094160.1 | Calmodulin like 43 | Y |
| HORVU5Hr1G111520.1 | EF hand calcium-binding protein family | Y | |||
| hvu-miR5048a | 0.36 | −1.68 | HORVU7Hr1G065130.1 | Receptor kinase 2 | Y |
| HORVU7Hr1G043150.1 | Protein kinase superfamily protein | Y | |||
| tae-miR7757-5p | 0.66 | −0.55 | HORVU5Hr1G086040.7 | NBS-LRR disease resistance protein, putative | Y |
| tae-MIR9662a-5p | −0.38 | 2.33 | HORVU5Hr1G123930.2 | Beta-fructofuranosidase, insoluble isoenzyme 3 | N |
| ata-MIR9863a-5p | 0.58 | 1.39 | HORVU5Hr1G007750.22 | FAR1-related sequence 3 | N |
| HORVU1Hr1G004650.4 | Purple acid phosphatase 22 | N | |||
| ppt-miR894 | −0.02 | 2.08 | HORVU7Hr1G041460.1 | 2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein | Y |
| hvu-miR5051 | 0.04 | −0.92 | HORVU7Hr1G054660.6 | Chromosome 3B, genomic scaffold, cultivar Chinese Spring | N |
| HORVU4Hr1G083260.5 | DnaJ homolog subfamily B member 4 | N | |||
| bdi-miR5054 | −1.98 | 2.07 | HORVU4Hr1G003990.3 | RNA-binding protein 1 | Y |
| HORVU6Hr1G088580.4 | Zinc finger (C3HC4-type RING finger) family protein | Y | |||
| osa-miR5072 | −1.21 | 1.43 | HORVU3Hr1G075970.2 | Pectate lyase family protein | N |
| gma-miR6300 | 0.86 | 3.08 | HORVU4Hr1G052010.2 | WRKY DNA-binding protein 46 | Y |
| HORVU0Hr1G035440.1 | Non-specific phospholipase C4 | Y | |||
| ptc-miR6478 | 1.04 | 3.46 | HORVU7Hr1G076700.1 | Myosin-J heavy chain | N |
| ath-miR8175 | −2.46 | 1.96 | HORVU5Hr1G085710.3 | Aquaporin-like superfamily protein, HvNIP1;2 | N |
| PC-miR1 | 0.00 | −0.73 | HORVU4Hr1G042240.2 | Hexosyltransferase | N |
| PC-miR2 | 0.00 | 1.26 | HORVU1Hr1G074900.1 | BZIP transcription factor | N |
| PC-miR4 | 2.11 | 0.00 | HORVU6Hr1G035300.19 | U11/U12 small nuclear ribonucleoprotein 25 kDa protein | N |
| PC-miR6 | −0.69 | 0.70 | HORVU6Hr1G076340.1 | Glycosyltransferase family 61 protein | N |
aGP and bXZ29 represent the fold change between Al treatment and control normalized reads in Golden Promise and XZ29, respectively. It was calculated as the formula: fold change = log2 (Al reads / control reads). miRNAs were significantly up-regulated with fold change≥0.5, down-regulated with fold change ≤ − 0.5, unchanged with |fold change| < 0.5. cDegradome detection shows the target genes of miRNAs. Y and N indicate target gene in or not in the degradome sequencing library
Fig. 4Expression of miRNAs and their targets in Golden Promise (GP) and XZ29, listed as a osa-miR319a-3p.2-3p, b osa-miR444a-3p.2, c ata-miR1432-5p and d ath-miR8175. Each panel value of relative miRNA expression represented fold change between Al treatment and control normalized reads from small RNA sequencing. Fold change was calculated as log2 (Al reads/control reads). Data in miRNA expression are means of two biological replicates while in gene expression are means of two biological replicates and two technical replicates. Red letter in sequences indicated miRNA cleavage sites on targets with degradome evidence
Fig. 5A model presenting Al responses in XZ29. Down regulation of miR160 and miR393, accumulation of jasmonic acid cause root growth inhibition. To alleviate the inhibition, the expression of miR319 and miR396 is significantly changed, resulting in acceleration of cell proliferation. On the other hand, the specifically expressed miRNA PC-miR1 in XZ29 might affect cell wall component through influencing pectin biosynthesis, leading to less Al ions binding to cell wall. Al transporters facilitate Al from cell wall into cytosol and then Al is stored in nontoxic forms